VEGF-C propagates ‘onward’ colorectal cancer metastasis from liver to lung

Menée à l'aide d'organoïdes de cancer colorectal, de modèles murins et d'une technique d'imagerie par bioluminescence, cette étude met en évidence un mécanisme par lequel le facteur VEGF-C favorise la propagation des métastases hépatiques vers les poumons

British Journal of Cancer, sous presse, 2024, résumé

Résumé en anglais

Background : The formation of lung metastasis as part of the progression of colon cancer is a poorly understood process. Theoretically, liver metastases could seed lung metastases.

Methods : To assess the contribution of the liver lymphatic vasculature to metastatic spread to the lungs, we generated murine liver-metastasis-derived organoids overexpressing vascular endothelial growth factor (VEGF)-C. The organoids were reimplanted into the mouse liver for tumour generation and onward metastasis.

Results : Liver metastases from patients with concomitant lung metastases showed higher expression of VEGF-C, lymphatic vessel hyperplasia, and tumour cell invasion into lymphatic vessels when compared to those without lung metastases. Reimplantation of VEGF-C overexpressing organoids into the mouse liver showed that VEGF-C caused peritumoral lymphatic vessel hyperplasia, lymphatic tumour cell invasion, and lung metastasis formation. This change in metastatic organotropism was accompanied by reduced expression of WNT-driven adult stem cell markers, and increased expression of fetal stem cell markers and NOTCH pathway genes. Further NOTCH pathway inhibition with